These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11026017)

  • 1. [Bisphosphonate for treatment of advanced breast cancers].
    Kohno N; Kitazawa S
    Nihon Rinsho; 2000 Apr; 58 Suppl():345-51. PubMed ID: 11026017
    [No Abstract]   [Full Text] [Related]  

  • 2. Aredia: the once-monthly infusion for the treatment of bone metastases.
    Lipton A
    Curr Opin Oncol; 1998 Aug; 10 Suppl 1():S1-5. PubMed ID: 9801852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of zoledronic acid in the adjuvant treatment of breast cancer: current perspectives.
    Tonyali O; Arslan C; Altundag K
    Expert Opin Pharmacother; 2010 Nov; 11(16):2715-25. PubMed ID: 20977404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapy of bone metastases in breast cancer patients.
    Petrut B; Simmons C; Broom R; Trinkaus M; Clemons M
    Expert Opin Pharmacother; 2008 Apr; 9(6):937-45. PubMed ID: 18377337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy and safety of zoledronic acid in prostate and breast cancer.
    Doggrell SA
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1211-8. PubMed ID: 19761424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bisphosphonate treatment against breast cancer with bone metastases].
    Kohno N
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():575-81. PubMed ID: 17682213
    [No Abstract]   [Full Text] [Related]  

  • 7. CALGB 78909: Phase III trial of intravenous zoledronic acid in the prevention of bone loss in localized breast cancer patients with chemotherapy-induced ovarian failure.
    Clin Adv Hematol Oncol; 2005 Feb; 3(2):105-6. PubMed ID: 16166977
    [No Abstract]   [Full Text] [Related]  

  • 8. [A case of effective bisphosphonate therapy for bone metastasis from breast cancer with multiorganic metastases].
    Sueyoshi K; Ogura Y; Komori T; Takahashi M; Tian TX; Tatsumi T; Matsuki M; Saika Y; Uesugi Y; Utsunomiya K; Inomata Y; Narabayashi I
    Gan To Kagaku Ryoho; 2002 Oct; 29(10):1795-9. PubMed ID: 12402432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diphosphonates in solid malignant tumors].
    Kamby C; Pedersen L; Kristensen B
    Ugeskr Laeger; 2005 Jan; 167(4):379-82. PubMed ID: 15719560
    [No Abstract]   [Full Text] [Related]  

  • 10. Adjuvant bisphosphonate therapy for breast cancer patients: Standard of care or future direction?
    Freedman OC; Amir E; Clemons MJ
    Crit Rev Oncol Hematol; 2009 Oct; 72(1):56-64. PubMed ID: 19307138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonates and metastatic breast carcinoma.
    Lipton A
    Cancer; 2003 Feb; 97(3 Suppl):848-53. PubMed ID: 12548585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonate safety and tolerability.
    Body JJ
    Oncologist; 2005 May; 10(5):317; author reply 318-9. PubMed ID: 15851786
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of bisphosphonates in breast cancer.
    Coleman RE
    Breast; 2004 Dec; 13 Suppl 1():S19-28. PubMed ID: 15585379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Medroxyprogesterone acetate for treatment of advanced breast cancers].
    Mitsuyama S; Anan K
    Nihon Rinsho; 2000 Apr; 58 Suppl():317-21. PubMed ID: 11026012
    [No Abstract]   [Full Text] [Related]  

  • 15. The efficacy and safety of oral ibandronate in the treatment of metastatic bone disease in patients with breast cancer.
    Utkan G; Büyükçelik A; Yalçyn B
    Ann Oncol; 2004 Oct; 15(10):1574; author reply 1574-5. PubMed ID: 15367420
    [No Abstract]   [Full Text] [Related]  

  • 16. Bisphosphonates may potentiate effects of thalidomide-dexamethasone combination in advanced multiple myeloma.
    Ural AU; Avcu F
    Am J Hematol; 2006 May; 81(5):385-6; author reply 386. PubMed ID: 16628715
    [No Abstract]   [Full Text] [Related]  

  • 17. Toward new horizons: the future of bisphosphonate therapy.
    Lipton A
    Oncologist; 2004; 9 Suppl 4():38-47. PubMed ID: 15459428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonates in the adjuvant treatment of cancer: experimental evidence and first clinical results. International Bone and Cancer Study Group (IBCG).
    Diel IJ; Mundy GR
    Br J Cancer; 2000 Apr; 82(8):1381-6. PubMed ID: 10780514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonates in breast cancer patients with skeletal metastases.
    Shapiro CL
    Hematol Oncol Clin North Am; 1994 Feb; 8(1):153-63. PubMed ID: 8150777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bone scintigraphy in the control of bone metastasis of breast cancer during pamidronate and tamoxifen combination therapy].
    Massoudi S; Brenner W; Czech N; Kampen WU; Henze E
    Nuklearmedizin; 2001 Apr; 40(2):N10-2. PubMed ID: 11354989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.